Pharmacyclics

Pharmacyclics LLC
TypeSubsidiary
Nasdaq: PCYC
IndustryBiopharmaceutical
Founded1991 (1991)
FoundersJonathan Sessler, Richard A. Miller
HeadquartersSunnyvale, California
Area served
Worldwide
Key peopleRobert Duggan, former CEO and Chairman
RevenueIncrease US$235 million (2013)
Increase US$110 million (2013)
Increase US$86.1 million (2013)
Total assetsIncrease US$1.06 billion (2013)
Total equityIncrease US$829 million (2013)
ParentAbbVie
Websitepharmacyclics.com

Pharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. It is primarily focused on the development of cancer therapies. In 2017, Xynomic Pharmaceuticals acquired all global rights to Abexinostat, Pharmacyclics' primary commercial product.